Petition Urges FDA To Take Oral Sodium Phosphate Laxatives Off OTC Market
This article was originally published in The Tan Sheet
Executive Summary
FDA should switch oral sodium phosphate bowel cleansers from over-the-counter to prescription status due to safety concerns or take them off the market altogether, according to a Sept. 20 citizen petition
You may also be interested in...
FDA Amends OTC Oral Sodium Phosphate Labeling, Warns Of Risks
FDA recommends consumers not use OTC oral sodium phosphate for bowel cleansing and says it will amend labeling for the products because of a risk of serious kidney injuries
FDA Amends OTC Oral Sodium Phosphate Labeling, Warns Of Risks
FDA recommends consumers not use OTC oral sodium phosphate for bowel cleansing and says it will amend labeling for the products because of a risk of serious kidney injuries
FDA Amends OTC Oral Sodium Phosphate Labeling, Warns Of Risks
FDA recommends consumers not use OTC oral sodium phosphate for bowel cleansing and says it will amend labeling for the products because of a risk of serious kidney injuries